Approval · Notice of Compliance 5700 · 1994
HALOPERIDOL DECANOATE: Notice of Compliance 5700
Issued August 9, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5700
- Date
- August 9, 1994
- Company
- David Bull Laboratories (Pty) Ltd.Mulgrave, Victoria, Australia
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Antipsychotic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| HALOPERIDOL DECANOATE | 02099624 | Cancelled Post Market |
| HALOPERIDOL DECANOATE | 02099616 | Cancelled Post Market |
Medicinal ingredients
- HALOPERIDOL DECANOATE 100 MG per ML
- HALOPERIDOL DECANOATE 50 MG per ML